Login / Signup

Labor Induction with Intravaginal Misoprostol versus Spontaneous Labor: Maternal and Neonatal Outcomes.

Esra OzbasliMuhterem Melis CanturkElif Ganime AygünSelin OzaltinMete Gungor
Published in: BioMed research international (2022)
Intravaginal misoprostol seems to be a promising medical agent for labor induction due to its high delivery rates within 12 hours and the absence of negative fetal outcomes, its ease of storage, and affordable cost.
Keyphrases
  • pregnant women
  • birth weight
  • type diabetes
  • metabolic syndrome
  • skeletal muscle
  • glycemic control
  • insulin resistance